Study of LP002 for the Treatment of Patients With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma
Clinical trial NCT04600947 · UNKNOWN
Trial details
- NCT number
- NCT04600947
- Sponsor
- Taizhou HoudeAoke Biomedical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-30
- Primary completion
- 2022-05-30
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.